Antoni Sicras‐Mainar

3.0k total citations
153 papers, 2.0k citations indexed

About

Antoni Sicras‐Mainar is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Physiology. According to data from OpenAlex, Antoni Sicras‐Mainar has authored 153 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Economics and Econometrics and 26 papers in Physiology. Recurrent topics in Antoni Sicras‐Mainar's work include Health Systems, Economic Evaluations, Quality of Life (25 papers), Diabetes Treatment and Management (21 papers) and Diabetes Management and Research (17 papers). Antoni Sicras‐Mainar is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (25 papers), Diabetes Treatment and Management (21 papers) and Diabetes Management and Research (17 papers). Antoni Sicras‐Mainar collaborates with scholars based in Spain, United Kingdom and United States. Antoni Sicras‐Mainar's co-authors include Ruth Navarro‐Artieda, Alexandra Prados‐Torres, Amaia Calderón‐Larrañaga, Beatriz Poblador‐Plou, Javier Rejas, Antonio Poncel-Falcó, Jorge Mauriño, Aram Sicras-Navarro, Luís Andrés Gimeno-Feliú and Francisca González‐Rubio and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and CHEST Journal.

In The Last Decade

Antoni Sicras‐Mainar

143 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antoni Sicras‐Mainar Spain 23 554 362 319 315 280 153 2.0k
Noam Y. Kirson United States 25 353 0.6× 236 0.7× 514 1.6× 224 0.7× 147 0.5× 87 1.8k
Christine T. Cigolle United States 19 484 0.9× 422 1.2× 185 0.6× 342 1.1× 339 1.2× 41 1.8k
Mari‐Ann Wallander Sweden 37 449 0.8× 254 0.7× 155 0.5× 266 0.8× 179 0.6× 95 3.2k
Sarah D. Berry United States 27 283 0.5× 200 0.6× 427 1.3× 342 1.1× 364 1.3× 116 3.0k
Peter Ihle Germany 20 380 0.7× 316 0.9× 160 0.5× 118 0.4× 538 1.9× 105 1.9k
Ludger Pientka Germany 28 531 1.0× 189 0.5× 178 0.6× 320 1.0× 174 0.6× 93 2.4k
David Yanez United States 20 304 0.5× 252 0.7× 128 0.4× 428 1.4× 318 1.1× 54 2.4k
Murray Tilyard New Zealand 21 267 0.5× 132 0.4× 477 1.5× 458 1.5× 343 1.2× 77 2.5k
Lisa E. Harris United States 19 479 0.9× 355 1.0× 309 1.0× 149 0.5× 676 2.4× 31 2.3k
Niels de Fine Olivarius Denmark 26 850 1.5× 309 0.9× 153 0.5× 320 1.0× 530 1.9× 96 3.0k

Countries citing papers authored by Antoni Sicras‐Mainar

Since Specialization
Citations

This map shows the geographic impact of Antoni Sicras‐Mainar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoni Sicras‐Mainar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoni Sicras‐Mainar more than expected).

Fields of papers citing papers by Antoni Sicras‐Mainar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoni Sicras‐Mainar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoni Sicras‐Mainar. The network helps show where Antoni Sicras‐Mainar may publish in the future.

Co-authorship network of co-authors of Antoni Sicras‐Mainar

This figure shows the co-authorship network connecting the top 25 collaborators of Antoni Sicras‐Mainar. A scholar is included among the top collaborators of Antoni Sicras‐Mainar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoni Sicras‐Mainar. Antoni Sicras‐Mainar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sicras‐Mainar, Antoni, et al.. (2025). Real-World Osteoporosis Treatment Gap and Costs in Spain: Data from Women with a First Fragility Fracture or Diagnosis of Postmenopausal Osteoporosis. Rheumatology and Therapy. 12(2). 315–335. 2 indexed citations
2.
Turnés, Juan, et al.. (2024). Impact of potential multiple drug-drug interactions on the adverse event profile of patients with hepatitis C treated with pangenotypic direct-acting antivirals in Spain. Revista Española de Sanidad Penitenciaria. 26(3). 98–112. 1 indexed citations
3.
Sicras‐Mainar, Antoni, et al.. (2024). Consequences of the Poor Anticoagulation Control of Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonists. Journal of Clinical Medicine. 13(21). 6495–6495.
4.
Plaza, Vicente, Javier Domínguez‐Ortega, Diego González-Segura Alsina, Daniele Lo Re, & Antoni Sicras‐Mainar. (2023). Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA. Pharmaceuticals. 16(11). 1609–1609. 1 indexed citations
5.
Cordero, Alberto, Regina Dalmau, L. Masana, et al.. (2023). Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study. ClinicoEconomics and Outcomes Research. Volume 15. 559–571. 3 indexed citations
6.
Comín‐Colet, Josep, et al.. (2023). Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol. Journal of Comparative Effectiveness Research. 12(8). e230007–e230007. 1 indexed citations
7.
8.
9.
Sicras‐Mainar, Antoni, Aram Sicras-Navarro, Beatriz Palacios, et al.. (2021). Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary. Endocrinología Diabetes y Nutrición. 69(7). 509–519. 4 indexed citations
10.
Rejas, Javier, Antoni Sicras‐Mainar, & Josep Darbà. (2021). Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain. Therapeutic Advances in Musculoskeletal Disease. 13. 1759720X211010599–1759720X211010599. 5 indexed citations
11.
Sicras‐Mainar, Antoni, Francisco J. de Abajo, & José Luís Izquierdo. (2020). <p>Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study</p>. International Journal of COPD. Volume 15. 3291–3302. 4 indexed citations
12.
Sicras‐Mainar, Antoni & Ramón Morillo‐Verdugo. (2020). Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection. Journal of International Medical Research. 48(10). 1220764211–1220764211. 4 indexed citations
13.
Sicras‐Mainar, Antoni, et al.. (2020). Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world study. Therapeutic Advances in Musculoskeletal Disease. 12. 1759720X20942000–1759720X20942000. 14 indexed citations
14.
Sicras‐Mainar, Antoni, et al.. (2017). Impact on healthcare resource utilization of multiple sclerosis in Spain. BMC Health Services Research. 17(1). 854–854. 28 indexed citations
15.
Sicras‐Mainar, Antoni, et al.. (2014). Influence of the CYP2D6 Isoenzyme in Patients Treated with Venlafaxine for Major Depressive Disorder: Clinical and Economic Consequences. PLoS ONE. 9(11). e90453–e90453. 8 indexed citations
16.
Sicras‐Mainar, Antoni & Ruth Navarro‐Artieda. (2014). Healthcare Costs of the Combination of Metformin/Dipeptidyl Peptidase-4 Inhibitors Compared with Metformin/Other Oral Antidiabetes Agents in Patients with Type 2 Diabetes and Metabolic Syndrome. Diabetes Technology & Therapeutics. 16(11). 722–727. 6 indexed citations
17.
Sicras‐Mainar, Antoni, et al.. (2013). Cost comparison of adding pregabalin or gabapentin for the first time to the therapy of patients with painful axial radiculopathy treated in Spain.. PubMed. 31(3). 372–81. 2 indexed citations
18.
Sicras‐Mainar, Antoni, et al.. (2010). Comparison of escitalopram vs. citalopram and venlafaxine in the treatment of major depression in Spain: clinical and economic consequences. Current Medical Research and Opinion. 26(12). 2757–2764. 9 indexed citations
19.
Sicras‐Mainar, Antoni, et al.. (2010). Impacto de la morbilidad, uso de recursos y costes en el mantenimiento de la remisión de la depresión mayor en España: estudio longitudinal de ámbito poblacional. Hispana. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noam Y. Kirson Breakdown of academic impact, for papers by Christine T. Cigolle Breakdown of academic impact, for papers by Mari‐Ann Wallander Breakdown of academic impact, for papers by Sarah D. Berry Breakdown of academic impact, for papers by Peter Ihle Breakdown of academic impact, for papers by Ludger Pientka Breakdown of academic impact, for papers by David Yanez Breakdown of academic impact, for papers by Murray Tilyard Breakdown of academic impact, for papers by Lisa E. Harris Breakdown of academic impact, for papers by Niels de Fine Olivarius
Rankless by CCL
2026